ロード中...
New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis
Chemokine (C-X-C motif) ligand 4 (CXCL4) is a biomarker of unfavorable prognosis in Systemic Sclerosis (SSc), a potentially severe autoimmune condition, characterized by vasculitis, fibrosis and interferon (IFN)-I-signature. We recently reported that autoantibodies to CXCL4 circulate in SSc patients...
保存先:
| 出版年: | Antibodies (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8103273/ https://ncbi.nlm.nih.gov/pubmed/33800661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib10020012 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|